BNTC R&D to Revenue
Benitec Biopharma Inc · R&D to Revenue
BNTC R&D to Revenue
Latest reported0.00%period ending
BNTC Quarterly R&D/Revenue (134.49% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
BNTC r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 664.5683% | |
| 0% | |
| 0% | |
| 0% | |
| -58,533.3333% | |
| 0% | |
| 0% | |
| 0% | |
| 45,514.2857% | |
| 5,864.8148% | |
| 26,864.2857% | |
| 0% | |
| 0% | |
| 4,522.9167% | |
| 12,584% | |
| 0% | |
| 116,000% | |
| 275,800% | |
| 116,800% | |
| 1,407.2727% | |
| -2,265% | |
| 2,875.0022% | |
| 777.9264% | |
| 1,281.8325% | |
| 196.423% | |
| 206.9643% | |
| 2.4026% | |
| 10.7997% | |
| 85.1536% | |
| 1,185.5781% | |
| 642.5006% | |
| 1,115.8902% | |
| 1,580.3629% | |
| 634.0828% | |
| 949.4412% | |
| 2,267.6148% | |
| 2,755.1114% | |
| 4,246.2559% | |
| 1,612.5264% | |
| 1,887.6865% | |
| 475.4967% | |
| -5,317.7031% | |
| 345.8548% | |
| 345.8538% | |
| 165.9004% | |
| 165.9003% | |
| 740.4% | |
| 826.2042% | |
| 504.2223% | |
| 501.0591% | |
| 134.4874% | |
| 134.4876% |